Rui Zhang, PhD, graduated from China Agricultural University and joined Academy for Advanced Interdisciplinary Studies of Peking University as a postdoc in 2022. She is interested in exploring the mechanisms that determine resistance to cancer immunotherapies. Currently, her project mainly focuses on the regulation in CD4+ T cells.